Zusammenfassung
Heute sind acht Virusfamilien bekannt, deren Vertreter eine einzelsträngige RNA in Plusstrangorientierung besitzen: Die Picornaviridae, Caliciviridae, Astroviridae und Hepeviren verfügen über Capside, die keine Hüllmembran aufweisen, wohingegen die Flaviviridae, Togaviridae, Arteriviridae und Coronaviridae durch membranumhüllte Partikel gekennzeichnet sind. Allen gemeinsam ist, dass sie ihre Genome als mRNA verwenden und davon ein oder mehrere Polyproteine synthetisieren, die im weiteren Verlauf durch virale oder auch zelluläre Proteasen in Einzelkomponenten gespalten werden. Die Viren verfügen über eine RNA-abhängige RNA-Polymerase, welche die Plusstrang-RNA sowie die als Zwischenprodukte der Replikation auftretenden Negativstränge übersetzt; dabei gehen die neuen genomischen RNA-Moleküle aus dem zweiten Transkriptionsschritt hervor. Die Einteilung in die unterschiedlichen Familien richtet sich nach Zahl, Größe, Lage und Orientierung der Virusgene auf der RNA, nach der Anzahl der unterschiedlichen Polyproteine, die während der Infektion synthetisiert werden, und nach dem Vorhandensein einer Hüllmembran als Teil der Virionen.
Chapter PDF
14.1.7 Weiterführende Literatur
Abzug, M. J. The enteroviruses: an emerging infectious disease? The real, the speculative and the really speculative. In: Adv. Exp. Med. Biol. 609 (2008) S. 1–15.
Aggarwal, N.; Barnett, P. V. Antigenic sites of foot-and-mouth disease virus (FMDV): an analysis of the specificities of anti-FMDV antibodies after vaccination of naturally susceptible host species. In: J. Gen. Virol. 83 (2002) S. 775–782.
Almond, J. W. Poliovirus neurovirulence. In: The Neurosciences 3 (1991) S. 101–108.
Baumgarte, S.; de Souza Luna, L. K.; Grywna, K.; Panning, M.; Drexler, J. F.; Karsten, C.; Huppertz, H. I.; Drosten, C. Prevalence, types, and RNA concentrations of human parechoviruses, including a sixth parechovirus type, in stool samples from patients with acute enteritis. In: J. Clin. Microbiol. 46 (2008) S. 242–248.
Bible, J. M.; Pantelidis, P.; Chan, P. K.; Tong, C. Y. Genetic evolution of enterovirus 71: epidemiological and pathological implications. In: Rev. Med. Virol. 17 (2007) S. 371–379.
Chapman, N. M.; Kim, K. S. Persistent coxsackievirus infection: enterovirus persistence in chronic myocarditis and dilated cardiomyopathy. In: Curr. Top. Microbiol. Immunol. 323 (2008) S. 275–292.
Coetzer, J. A. W.; Thomson, G. R.; Tustin, R. C. (Hrsg.) Infectious Diseases of Livestock with special reference to Southern Africa. Oxford University Press 2004.
Cristina, J.; Costa-Mattioli, M. Genetic variability and molecular evolution of Hepatitis-A virus. In: Virus Res. 127 (2007) S. 151–157.
Dreschers, S.; Dumitru, C. A.; Adams, C.; Gulbins, E. The cold case: are rhinoviruses perfectly adapted pathogens? In: Cell. Mol. Life Sci. 64 (2007) S. 181–191.
Enders, J. F.; Weller, T. H.; Robbins, F. C. Cultivation of the Lansing strain of poliomyelitis virus in cultures of various human embryonic tissues. In: Science 190 (1949) S. 85–87.
Fensterl, V.; Grotheer, D.; Berk, I.; Schlemminger, S.; Vallbracht, A.; Dotzauer, A. Hepatitis-A virus suppresses RIG-I-me diated IRF-3 activation to block induction of beta interferon. In: J. Virol. 79 (2005) S. 10968–10977.
Gibbens, J. C.; Sharpe, C. E.; Wilesmith, J. W.; Mansley, L. M.; Michalopoulou, E.; Ryan, J. B. M.; Hudson, M. Descriptive epidemiology of the 2001 foot-and-mouth disease epidemic in Great Britain: the first five months. In: The Veterinary Record (Vet. Rec.) 149 (2001). S. 729–743.
Gromeier, M.; Solecki, D.; Patel, D. D.; Wimmer, E. Expression of the human poliovirus receptor/CD 155 gene during development of the central nervous system: Implications for the pathogenesis of poliomyelitis. In: Virology 273 (2000) S. 248–257.
Grubman, M. J.; Moraes, M. P.; Diaz-San Segundo, F.; Pena, L.; de los Santos, T. Evading the host immune response: how foot-and-mouth disease virus has become an effective pathogen. In: FEMS Immunol. Med. Microbiol. 53 (2008) S. 8–17.
Hogle, J. M.; Chow, M.; Filman, D. J. Three-dimensional structure of poliovirus at 2.9 A resolution. In: Science 229 (1985) S. 1358–1363.
Hovi, T. Inactivated poliovirus vaccine and the final stages of poliovirus eradication. In: Vaccine 19 (2001) S. 2268–2272.
Jang, S. K.; Pestova, T. V.; Hellen, C. U. T.; Witherell, G. W.; Wimmer, E. Cap-independent translation of picornavirus RNAs: structure and fuction of the internal ribosomal entry site. In: Enzyme 44 (1990) S. 292–309.
Johansen, L. K.; Morrow, C. D. The RNA encompassing the internal ribosomal entry site in the poliovirus 5’ nontranslated region enhances the encapsidation of genomic RNA. In: Virology 273 (2000) S. 391–399.
Joki-Korpela, P.; Hyypiä, T. Parechoviruses, a novel group of human picornaviruses. In: Ann. Med. 33 (2001) S. 466–471.
Landsteiner, K.; Popper, E. Übertragung der Poliomyelitis acuta auf Affen. In: Z. Immunitätsforschung Orig. 2 (1909) S. 377–390.
Lukashev, A. N. Role of recombination in evolution of enteroviruses. In: Rev. Med. Virol. 15 (2005) S. 157–167.
Magnus, H. v.; Gear, J. H. S.; Paul, J. R. A recent definition of poliomyelitis viruses. In: Virology 1 (1955) S. 185–189.
Martin, A.; Lemon, S. M. Hepatitis-A virus: from discovery to vaccines. In: Hepatology 43 (2006): S. 164–172.
Morace, G.; Kusov. Y.; Dzagurov. G.; Beneduce, F.; Gauss-Muller, V. The unique role of domain 2A of the Hepatitis-A virus precursor polypeptide P1-2A in viral morphogenesis. In: BMB Rep. 41 (2008) S. 678–683.
Mueller, S.; Wimmer, E.; Cello, J. Poliovirus and poliomyelitis: a tale of guts, brains, and an accidental event. In: Virus Res. 111 (2005) S. 175–193.
Niklasson, B.; Samsioe, A.; Papadogiannakis, N.; Kawecki, A.; Hörnfeldt, B.; Saade, G. R.; Klitz, W. Association of zoonotic Ljungan virus with intrauterine fetal deaths. In: Birth Defects Res. A. Clin. Mol. Teratol. 79 (2007) S. 488–493.
Niklasson, B.; Kinnunen, L.; Hörnfeld, B.; Hörling, J.; Benemer, C.; Hedlund, K. O.; Matskova, L.; Hyypiä, T.; Winberg, G. A new picornavirus isolated from bank roles (Clethrionomys glareolus). In: Virology 255 (1999) S. 86–93.
Olson, N. H.; Kolatkar, P. R.; Oliveira, M. A.; Cheng, R. H.; Greve, J. M.; McClelland, A.; Baker, T. S.; Rossmann, M. G. Structure of a human rhinovirus complexed with its receptor molecule. In: Proc. Natl. Acad. Sci. USA 90 (1993) S. 507–511.
Paul, A. V.; Rieder, E.; Kim, D. W.; Boom, J. H. van; Wimmer E. Identification of an RNA hairpin in poliovirus RNA that serves as the primary template in the in vitro uridylylation of Vpg. In: J. Virol. 74 (2000) S. 10359–10370.
Paulmann, D.; Magulski, T.; Schwarz, R.; Heitmann, L.; Flehmig, B.; Vallbracht, A.; Dotzauer, A. Hepatitis-A virus protein 2B suppresses beta interferon (IFN) gene transcription by interfering with IFN regulatory factor 3 activation. In: J. Gen. Virol. 89 (2008) S. 1593–1604.
Racaniello, V. R. One hundred years of poliovirus pathogenesis. In: Virology 344 (2006) S. 9–16.
Rieder, E.; Paul, A. V.; Kim, D. W.; van Boom, J. H.; Wimmer, E. Genetic and biochemical studies of poliovirus cis-acting replication element cre in relation to Vpg uridylylation. In: J. Virol. 74 (2000) S. 10371–10380.
Rossmann, M. G. The canyon hypothesis. Hiding the cell receptor attachment site an a viral surface from immune surveillance. In: J. Biol. Chem. 264 (1989) S. 14587–14590.
Rossmann, M. G.; Arnold, E.; Erickson, J. W.; Frankenberger, E. A.; Griffith, J. P.; Hecht, H. J.; Johnson, J.; Kamer, J.; Luo, M.; Mosser, A. G.; Rueckert, R. R.; Sherry, B.; Vriend, G. Structure of human common cold virus and functional relationship to other picornaviruses. In: Nature 317 (1985) S. 145–153.
Rossmann, M. G.; Bella, J.; Kolatkar, P. R.; He, Y.; Wimmer, E.; Kuhn, R. J.; Baker, T. S. Cell recognition and entry by rhinoand enteroviruses. In: Virology 269 (2000) S. 239–247.
Savolainen, C.; Blomqvist, S.; Hovi, T. Human rhinoviruses. In: Paediatr. Respir. Rev. 4 (2003) S. 91–98.
Shimizu, H.; Agoh, M.; Agoh, Y.; Yoshida, H.; Yoneyama, T.; Hagiwara, A.; Miyamura, T. Mutation in the 2C region of poliovirus responsible for altered sensitivity to benzimidazole derivatives. In: J. Virol. 74 (2000) S. 4164–4154.
Steil, B. P.; Barton, D. J. Cis-active RNA elements (CREs) and picornavirus RNA replication. In: Virus Res. 139 (2009) S. 240–252.
Tami, C.; Silberstein, E.; Manangeeswaran, M.; Freeman, G. J.; Umetsu, S. E.; DeKruyff, R. H.; Umetsu, D. T.; Kaplan, G. G. Immunoglobulin A (IgA) is a natural ligand of Hepatitis-A virus cellular receptor 1 (HAVCR1), and the association of IgA with HAVCR1 enhances virus-receptor interactions. In: J. Virol. 81 (2007) S. 3437–3446.
Van der Werf, N.; Kroese, F. G.; Rozing, J.; Hillebrands, J. L. Viral infections as potential triggers of type 1 diabetes. In: Diabetes Metab. Res. Rev. 23 (2007) S. 169–183.
Wang, C. Y.; Chang, T. Y.; Walfield, A. M; Ye, J.; Shen, M.; Chen, S. P.; Li, M. C.; Lin, Y. L.; Jong, M. H.; Yang, P. C.; Chyr, N.; Kramer, E.; Brown, F. Effective synthetic peptide vaccine for foot-and-mouth disease in swine. In: Vaccine 20 (2002) S. 2603–2610.
Wasley, A.; Fiore, A.; Bell, B. P. Hepatitis-A in the era of vaccination. In: Epidemiol. Rev. 28 (2006) S. 101–111.
Wells, V. R.; Plotch, S. J.; De Stefano, J. J. Determination of the mutation rate of poliovirus RNA-dependent RNA polymerase. In: Virus Res. (2001) S. 119–132.
Zoll, J.; Heus, H. A.; van Kuppeveld, F. J.; Melchers, W. J. The struc ture-function relationship of the enterovirus 3′-UTR. In: Virus Res. 139 (2009) S. 209–216.
Weiterführende Literatur
Appleton, H.; Higgins, P. G. Letter: Viruses and gastroenteritis in infants. In: Lancet 1, 7919 (1975) S. 1297.
Bonaparte, R. S.; Hair, P. S.; Banthia, D.; Marshall, D. M.; Cunnion, K. M.; Krishna, N. K. Human astrovirus coat protein inhibits serum complement activation via C1, the first component of the classical pathway. In: J. Virol. 82 (2008) S. 817–827.
Geigenmüller, U.; Chew, T.; Ginzton, N.; Matsui S. M. Processing of nonstructural protein 1a of human astrovirus. In: J. Virol. 76 (2002) S. 2003–2008.
Guix, S.; Caballero, S.; Bosch, A.; Pintó, R. M. Human astrovirus C-terminal nsP1a protein is involved in RNA replication. In: Virology 333 (2005) S. 124–131.
Guix, S.; Caballero, S.; Bosch, A.; Pintó, R. M. C-terminal nsP1a protein of human astrovirus colocalizes with the endoplasmic Retikulum and viral RNA. In: J. Virol. 78 (2004) S. 13627–13636.
Jonassen, C. M.; Jonassen, T. TØ.; Sveen, T. M.; Grinde, B. Complete genomic sequences of astroviruses from sheep and turkey: comparison with related viruses. In: Virus Res. 91 (2003) S. 195–201.
Krishna, N. K. Identification of structural domains involved in astrovirus capsid biology. In: Viral Immunol. 18 (2005) S. 17–26.
Krishna, N. K.; Cunnion, K. M. Human astrovirus coat protein: a novel C1 inhibitor. In: Adv. Exp. Med. Biol. 632 (2008) S. 237–251.
Moser, L. A.; Schultz-Cherry, S. Pathogenesis of astrovirus infection. In: Viral Immunol. 18 (2005) S. 4–10.
Moser, L. A.; Carter, M.; Schultz-Cherry, S. Astrovirus increases epithelial barrier permeability independently of viral replication. In: J. Virol. 81 (2007) S. 11937–11945.
Moser, L. A.; Schultz-Cherry, S. Suppression of astrovirus replication by an ERK1/2 inhibitor. In: J. Virol. 82 (2008) S. 7475–7482.
Walter, J. E.; Mitchell, D. K. Astrovirus infection in children. In: Curr. Opin. Infect. Dis. 16 (2003) S. 247–253.
Weiterführende Literatur
Bhella, D.; Gatherer, D.; Chaudhry, Y.; Pink, R.; Goodfellow, I. G. Structural insights into calicivirus attachment and uncoating. In: J. Virol. 82 (2008) S. 8051–8058.
Cao, S.; Lou, Z.; Tan, M.; Chen, Y.; Liu, Y.; Zhang, Z.; Zhang, X. C.; Jiang, X.; Li, X.; Rao, Z. Structural basis for the recognition of blood group trisaccharides by norovirus. In: J. Virol. 81 (2007) S. 5949–5957.
Chen, R.; Neill, J. D.; Estes, M. K.; Prasad, B. V. X-ray structure of a native calicivirus: structural insights into antigenic diversity and host specificity. In: Proc. Natl. Acad. Sci. USA 103 (2006) S. 8048–8053.
Clarke, I. N.; Lambden, P. R. The molecular biology of caliciviruses. In: J. Gen. Virol. 78 (2001) S. 291–301.
Daughenbaugh, K. F.; Fraser, C. S.; Hershey, J. W.; Hardy, M. E. The genome-linked protein VPg of the Norwalk virus binds eIF3, suggesting its role in translation initiation complex recruitment. In: EMBO J. 22 (2003) S. 2852–2859.
Estes, M. K.; Prasad, B. V.; Atmar, R. L. Noroviruses everywhere: has something changed? In: Curr. Opin. Infect. Dis. 19 (2006) S. 467–474.
Geissler, K.; Schneider, K.; Fleuchaus, A.; Parrish, C. R.; Sutter, G.; Truyen, U. Feline calicivirus capsid protein expression and capsid assembly in cultured feline cells. In: J. Virol. 73 (1999) S. 834–838.
Geissler, K.; Schneider, K.; Platzer; G.; Truyen, B.; Kaaden, O.-R.; Truyen, U. Genetic and antigenic heterogenity among feline calicivirus isolates from distinct disease cluster. In: Virus Res. 48 (1997) S. 193–206.
Hansman, G. S.; Oka, T.; Katayama, K.; Takeda, N. Human sapoviruses: genetic diversity, recombination, and classification. In: Rev. Med. Virol. 17 (2007) S. 133–141.
Jiang, X.; Huang, P.; Zhong, W.; Tan, M.; Farkas, T.; Morrow, A. L.; Newburg, D. S.; Ruiz-Palacios, G. M.; Pickering, L. K. Human milk contains elements that block binding of noroviruses to human histo-blood group antigens in saliva. In: J. Infect. Dis. 190 (2004) S. 1850–1859.
Koch, J.; Schneider, T.; Stark, K.; Schreier, E. Norovirus infections in Germany. In: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 49 (2006) S. 296–309.
Koopmans, M. Progress in understanding norovirus epidemiology. In: Curr. Opin. Infect. Dis. (2008) S. 544–552.
L’Homme, Y.; Sansregret, R.; Plante-Fortier, E.; Lamontagne, A. M.; Ouardani, M.; Lacroix, G.; Simard, C. Genomic characterization of swine caliciviruses representing a new genus of Caliciviridae. In: Virus Genes 39 (2009) S. 66–75.
Martella, V.; Lorusso, E.; Decaro, N.; Elia, G.; Radogna, A.; D’Abramo, M.; Desario, C.; Cavalli, A.; Corrente, M.; Camero, M.; Germinario, C. A.; Bányai, K.; Di Martino, B.; Marsilio, F.; Carmichael, L.E.; Buonavoglia, C. Detection and molecular characterization of a canine norovirus. In: Emerg. Infect. Dis. 14 (2008) S. 1306–1308.
McCormick, C. J.; Salim, O.; Lambden, P. R.; Clarke, I. N. Translational termination re-initiation between ORF1 and ORF2 enables capsid expression in a bovine norovirus without the need for production of viral sub-genomic RNA. In: J. Virol. 2008
Oka, T.; Yamamoto, M.; Katayama, K.; Hansman, G. S.; Ogawa, S.; Miyamura, T.; Takeda, N. Identification of the cleavage sites of sapovirus open reading frame 1 polyprotein. In: J. Gen. Virol. 87 (2006) S. 3329–3338.
Ossiboff, R. J.; Parker, J. S. Identification of regions and residues in feline junctional adhesion molecule required for feline calicivirus binding and infection. In: J. Virol. 81 (2007) S. 13608–13621.
Radford, A. D.; Gaskell, R. M.; Hart, C. A. Human norovirus infection and the lessons from animal caliciviruses. In: Curr. Opin. Infect. Dis. 17 (2004) S. 471–478.
Robel, I.; Gebhardt, J.; Mesters, J. R.; Gorbalenya, A.; Coutard, B.; Canard, B.; Hilgenfeld, R.; Rohayem, J. Functional characterization of the cleavage specificity of the sapovirus chymotrypsin-like protease. In: J. Virol. 82 (2008) S. 8085–8093.
Rockx, B. H.; Vennema, H.; Hoebe, C. J.; Duizer, E.; Koopmans, M. P. Association of histo-blood group antigens and susceptibility to norovirus infections. In: J. Infect. Dis. 191 (2005) S. 749–754.
Scipioni, A.; Mauroy, A.; Vinjé, J.; Thiry, E. Animal noroviruses. In: The Veterinary Journal 178 (2008) S. 32–45.
Sosnovtsev, S.; Green, K. Y. RNA transcripts derived from a cloned full-length copy of the feline calicivirus genome do not require VpG for infectivity. In: Virology 210 (2000) S. 383–390.
Tan, M.; Jiang, X. Norovirus-host interaction: implications for disease control and prevention. In: Expert. Rev. Mol. Med. 9 (2007) S. 1–22.
Tan, M.; Jiang, X. Norovirus and its histo-blood group antigen receptors: an answer to a historical puzzle. In: Trends Microbiol. 13 (2005) S. 285–293.
Wirblich, C.; Thiel, H.; Meyers, G. Genetic map of the calicivirus rabbit hemorrhagic disease virus as deduced from in vitro translation studies. In: J. Virol. 70 (1996) S. 7974–7983.
Weiterführende Literatur
Bouwknegt, M.; Lodder-Verschoor, F.; van der Poel, W. H.; Rutjes, S. A.; de Roda Husman, A. M. Hepatitis-E virus RNA in commercial porcine livers in The Netherlands. In: J. Food Prot. 70 (2007) S. 2889–2895.
Bradley, D. W.; Balayan, M. S. Viruses of enterically transmitted non-A, non-B hepatitis. In: Lancet 1 (1988) S. 819.
Chandra, V.; Kar-Roy, A.; Kumari, S.; Mayor, S.; Jameel, S. The Hepatitis-E virus ORF3 protein modulates epidermal growth factor receptor trafficking, STAT3 translocation, and the acute-phase response. In: J. Virol. 82 (2008) S. 7100–7110.
Chandra, V.; Taneja, S.; Kalia, M.; Jameel, S. Molecular biology and pathogenesis of Hepatitis-E virus. In: J. Biosci. 33 (2008) S. 451–464.
Choo, Q. L.; Kuo, G.; Weiner, A. J.; Overby, L. R.; Bradley, D. W.; Houghton, M. Isolation of a cDNA clone from a blood-borne non-A, non-B viral hepatitis genome. In: Science 244 (1989) S. 359–362.
Guu, T. S.; Liu, Z.; Ye, Q.; Mata, D. A.; Li K.; Yin, C.; Zhang, J.; Tao, Y. J. Structure of the Hepatitis-E virus-like particle suggests mechanisms for virus assembly and receptor binding. In: Proc. Natl. Acad. Sci. USA 106 (2009) S. 12992–12997.
Haagsma, E. B.; van den Berg, A. P.; Porte, R. J.; Benne, C. A.; Vennema, H.; Reimerink, J.H.; Koopmans, M. P. Chronic Hepatitis-E virus infection in liver transplant recipients. In: Liver Transpl. 14 (2008) S. 547–553.
Kaci, S.; Nöckler, K.; Johne, R. Detection of Hepatitis-E virus in archived German wild boar serum samples. In: Vet. Microbiol. 128 (2008) S. 380–385.
Kamar, N.; Selves, J.; Mansuy, J. M.; Ouezzani, L.; Péron, J. M.; Guitard, J.; Cointault, O.; Esposito, L.; Abravanel, F.; Danjoux, M.; Durand, D.; Vinel, J. P.; Izopet, J.; Rostaing, L. Hepatitis-E virus and chronic hepatitis in organ-transplant recipients. In: N. Engl. J. Med. 358 (2008) S. 811–817.
Kannan, H.; Fan, S.; Patel, D.; Bossis, I.; Zhang, Y. J. The Hepatitis-E virus open reading frame 3 product interacts with microtubules and interferes with their dynamics. In: J. Virol. 83 (2009) S. 6375–6382
Li, S.; Tang, X.; Seetharaman, J.; Yang, C.; Gu, Y.; Zhang, J.; Du, H.; Shih, J. W.; Hew, C. L.; Sivaraman, J.; Xia, N. Dimerization of Hepatitis-E virus capsid protein E2s domain is essential for virus-host interaction. In: PLoS Pathog. 5 (2009) e1000537.
Mansuy, J. M.; Legrand-Abravanel, F.; Calot, J. P.; Peron, J. M.; Alric, L.; Agudo, S.; Rech, H.; Destruel, F.; Izopet, J. High prevalence of anti-Hepatitis-E virus antibodies in blood donors from South West France. In: J. Med. Virol. 80 (2008) S. 289–293.
Meng, X. J. Hepatitis-E virus: Animal reservoirs and zoonotic risk. In: Vet. Microbiol. (2009)
Meng, X. J.; Halbur, P. G.; Haynes, J. S.; Tsavera, T. S.; Bruna, J.D.; Royer, R. L.; Purcell, R. H.; Emerson, S. U. Experimental infection of pigs with the newly identified swine hepatitis virus (swine HEV), but not with human strains of HEV. In: Archives of Virology 143 (1998) S. 1405–1415.
Meng, X. J.; Halbur, P. G.; Shapiro, M. S.; Govindarajan, S.; Bruna, J. D.; Mushahwar, I. K.; Purcell, R. H.; Emerson, S. U. Genetic and experimental evidence for cross-species infection by swine Hepatitis-E virus. In: J. Virol. 72 (1998) S. 9714–9721.
Purcell, R. H.; Emerson, S. U. Hepatitis-E: an emerging awareness of an old disease. In: J. Hepatol. 48 (2008) S. 494–503.
Shrestha, M. P.; Scott, R. M.; Joshi, D. M.; Mammen, M. P. Jr.; Thapa, G. B.; Thapa, N.; Myint, K. S.; Fourneau, M.; Kuschner, R. A.; Shrestha, S. K.; David, M. P.; Seriwatana, J.; Vaughn, D. W.; Safary, A.; Endy, T. P.; Innis, B. L. Safety and efficacy of a recombinant Hepatitis-E vaccine. In: N. Engl. J. Med. 356 (2007) S. 895–903.
Surjit, M.; Jameel, S.; Lal, S. K. Cytoplasmic localization of the ORF2 protein of Hepatitis-E virus is dependent on its ability to undergo retrotranslocation from the endoplasmic Retikulum. In: J. Virol. 81 (2007) S. 3339–3345.
Tygai, S.; Jameel, S.; Lal, S. K. Self-association and mapping of the interaction domain of Hepatitis-E-virus ORF3 protein. In: J. Virol. 75 (2001) S. 2493–2498.
Wang, Y.; Zhang, H.; Ling, R.; Li, H.; Harrison, T. J. The complete sequence of Hepatitis-E virus genotype 4 reveals an alternative strategy for translation of openreading frames 2 and 3. In: J. Gen. Virol. 81 (2000) S. 1675–1686.
Worm, H. C.; Schlauder, G. G.; Wurzer, H.; Mushahwar, I. K. Identification of a novel variant of Hepatitis-E virus in Austria: sequence, phylogenetic and serological analysis. In: J. Gen. Virol. 81 (2000) S. 2885–2890.
Weiterführende Literatur
Appel, N.; Zayas, M.; Miller, S.; Krijnse-Locker, J.; Schaller, T.; Friebe, P.; Kallis, S.; Engel, U.; Bartenschlager, R. Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly. In: PLoS Pathog. 28 (2008) e1000035.
Bartenschlager, R.; Miller, S. Molecular aspects of Dengue virus replication. In: Future Microbiol. 3 (2008) S. 155–165.
Bartenschlager, R.; Ahlborn-Laake, L.; Yasargil, K.; Mous, J.; Jacobson, H. Substrate determinants for cleavage in cis and trans by hepatitis C virus NS3 proteinase. In: J. Virol. 69 (1995) S. 98–205.
Bartenschlager, R.; Lohmann, V. Replication of hepatitis-C-virus. In: J. Gen. Virol. 81 (2000) S. 1631–1648.
Bauhofer, O.; Summerfield, A.; Sakoda, Y.; Tratschin, J. D.; Hofmann, M. A.; Ruggli, N. Classical swine fever virus Npro interacts with interferon regulatory factor 3 and induces its proteasomal degradation. In: J. Virol. 81 (2007) S. 3087–3096.
Becher, P.; Orlich, M.; Thiel, H.-J. RNA recombination between persisting pestivirus and a vaccine strain: generation of cytopathogenic virus and induction of lethal disease. In: J. Virol. 75 (2001) S. 6256–6264.
Berman, K.; Kwo, P. Y. Boceprevir, an NS3 protease inhibitor of HCV. In: Clin. Liver Dis. 13 (2009) S. 429–39.
Chen, Z.; Rijnbrand, R.; Jangra, R. K.; Devaraj, S. G.; Qu, L.; Ma, Y.; Lemon, S. M.; Li, K. Ubiquitination and proteasomal degradation of interferon regulatory factor-3 induced by Npro from a cytopathic bovine viral diarrhea virus. In: Virology 366 (2007) S. 277–292.
Chen, S. T.; Lin, Y. L.; Huang, M. T.; Wu, M. F.; Cheng, S. C.; Lei, H. Y.; Lee, C. K.; Chiou, T. W.; Wong, C. H.; Hsieh, S. L. CLEC 5A is critical for dengue-virus-induced lethal disease. In: Nature 453 (2008) S. 672–676.
Chu, J. J.; Ng, M. L. Interaction of West Nile virus with alpha v beta 3 integrin mediates virus entry into cells. In: J. Biol. Chem. 279 (2004) S. 54533–54541.
Esteban, J. I.; Sauleda, S.; Quer, J. The changing epidemiology of hepatitis C virus infection in Europe. In: J. Hepatol. 48 (2008) S.148–162.
Glass, W. G.; Lim, J. K.; Cholera, R.; Pletnev, A. G.; Gao, J. L.; Murphy, P. M. Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. In: J. Exp. Med. 202 (2005) S. 1087–1098.
Glass, W. G.; McDermott, D. H.; Lim, J. K.; Lekhong, S.; Yu, S. F.; Frank, W. A.; Pape, J.; Cheshier, R. C.; Murphy, P. M. CCR5 deficiency increases risk of symptomatic West Nile virus infection. In: J. Exp. Med. 203 (2006) S. 35–40.
Gould, E. A.; Solomon, T. Pathogenic flaviviruses. In: Lancet 371 (2008) S. 500–509.
Chung, K. M.; Liszewski, M. K.; Nybakken, G.; Davis, A. E.; Townsend, R. R.; Fremont, D. H.; Atkinson, J. P.; Diamond, M. S. West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H. In: Proc. Natl. Acad. Sci. USA 103 (2006) S. 19111–19116.
Guzman, M. G.; Kouri, G. Dengue: An update. In: Lancet Infect. Dis. 2 (2002) S. 33–42.
Harrison, S. C. Viral membrane fusion. In: Nat. Struct. Mol. Biol. 15 (2008) S. 690–698.
Henchal, E. A.; Putnak, J. R. The Dengue viruses. In: Clin. Microbiol. Rev. 376 (1990) S. 376–396.
Hershkovitz, O.; Zilka, A.; Bar-Ilan, A.; Abutbul, S.; Davidson, A.; Mazzon, M.; Kümmerer, B. M.; Monsoengo, A.; Jacobs, M.; Porgador, A. Dengue virus replicon expressing the nonstructural proteins suffices to enhance membrane expression of HLA class I and inhibit lysis by human NK cells. In: J. Virol. 82 (2008) S. 7666–7676.
Iqbal, M.; Poole, E.; Goodbourn, S.; McCauley, J. W. Role for bovine viral diarrhea virus Erns glycoprotein in the control of activation of beta interferon by double-stranded RNA. In: J. Virol. 78 (2004) S. 136–145.
Kroschewski, H.; Allison, S. L.; Heinz, F. X.; Mandl, C. W. Role of heparan sulfate for attachment and entry of tick-borne encephalitis virus. In: Virology 308 (2003) S. 92–100.
Jung, S.; Eichenmüller, M.; Donhauser, N.; Neipel, F.; Engel, A. M.; Hess, G.; Fleckenstein, B.; Reil, H. HIV entry inhibition by the envelope 2 glycoprotein of GB virus C. In: AIDS 21 (2007) S. 645–647.
Kindberg, E.; Mickiene, A.; Ax, C.; Akerlind, B.; Vene, S.; Lindquist, L.; Lundkvist, A.; Svensson, L. A deletion in the chemokine receptor 5 (CCR5) gene is associated with tickborne encephalitis. In: J. Infect. Dis. 197 (2008) S. 266–269.
Lai, C.Y.; Tsai, W. Y.; Lin, S. R.; Kao, C. L.; Hu, H. P.; King, C. C.; Wu, H. C.; Chang, G. J.; Wang, W. K. Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II. In: J. Virol. 82 (2008) S. 6631–6643.
Lei, H. Y.; Yeh, T. M.; Lin, H. S.; Lin, Y. S.; Chen, S. H.; Lin, C. C. Immunopathogenesis of dengue virus infection. In: J. Biomed. Sci. 8 (2001) S. 377–388.
Leung, J. Y.; Pijlman, G. P.; Kondratieva, N.; Hyde, J.; Mackenzie, J. M.; Khromykh, A. A. Role of nonstructural protein NS2A in flavivirus assembly. In: J. Virol. 82 (2008) S. 4731–4741.
Lim, J. K.; Glass, W. G.; McDermott, D. H.; Murphy, P. M. CCR5: no longer a “good for nothing” gene-chemokine control of West Nile virus infection. In: Trends Immunol. 27 (2006) S. 308–312.
Lin, R. J.; Chang, B. L.; Yu, H. P.; Liao, C. L.; Lin, Y. L. Blocking of interferon-induced Jak-Stat signaling by Japanese encephalitis virus NS5 through a protein tyrosine phosphatase-mediated mechanism. In: J. Virol. 80 (2006) S. 5908–5918.
Liu, W. J.; Wang, X. J.; Clark, D. C.; Lobigs, M.; Hall, R. A.; Khromykh, A. A. A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice. In: J. Virol. 80 (2006) S. 2396–2404.
Mansfield, K. L.; Johnson, N.; Phipps, L. P.; Stephenson, J. R.; Fooks, A. R.; Solomon, T. Tick-borne encephalitis virus — a review of an emerging zoonosis. In: J. Gen. Virol. 90 (2009) S. 1781–1794.
Meyers, G.; Thiel, H. J. Molecular characterization of pestiviruses. In: Adv. Virus Res. 47 (1996) 53–118.
Muerhoff, A. S.; Leary, T. P.; Simons, J. N.; Pilot-Matias, T. J.; Dawson, G. J.; Erker, J. C.; Chalmers, M. L.; Schlauder, G. G.; Desai, S. M.; Mushahwar, I. K. Genomic organization of GB viruses A and B: Two new members of the flaviviridae associated with GB agent hepatitis. In: J. Virol. 69 (1995) S. 5621–5630.
Pardigon, N. The biology of chikungunya: a brief review of what we still do not know. In: Pathol. Biol. (Paris) 57 (2009) S. 127–132.
Pfleiderer, C.; Blümel, J.; Schmidt, M.; Roth, W. K.; Houfar, M. K.; Eckert, J.; Chudy, M.; Menichetti, E.; Lechner, S.; Nübling, C. M. West Nile virus and blood product safety in Germany. In: J. Med. Virol. 80 (2008) S. 557–563.
Pierson, T. C.; Diamond, M. S. Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection. In: Expert Rev. Mol. Med. 10 (2008) e12.
Pileri, P.; Uematsu, Y.; Campagnoli, S.; Galli, G.; Falugi, F.; Petracca, R.; Weiner, A. J.; Houghton, M.; Rosa, D.; Grandi, G.; Abrignani, S. Binding of Hepatitis C Virus to CD81. In: Science 282 (1998) S. 938–941.
Reshetnyak, V. I.; Karlovich, T. I.; Ilchenko, L. U. Hepatitis G virus. In: World J. Gastroenterol. 14 (2008) S. 4725–4734.
Rümenapf, T.; Thiel, H.-J. Molecular Biology of Pestiviruses. In: Mettenleiter, T. C.; Sobrino, F. (Hrsg.) Animal viruses. ORT (Mo lecular Biology. Caister Academic Press) 2008. S. 39–96.
Rey, F. A.; Heinz, F. X.; Mandl, C.; Kunz, C.; Harrison, S. C. The envelope glycoprotein from tick-borne encephalitis virus at 2Å resolution. In: Nature 375 (1995) S. 291–299.
Solomon, T. Flavivirus encephalitis. In: N. Engl. J. Med. 351 (2004) S. 370–378.
Tautz, N.; Elbers, K.; Stoll, D.; Meyers, G.; Thiel, H.-J. Serin protease of pestivirus: Determination of cleavage sites. In: J. Virol. 71 (1997) S. 5415–5422.
Timm, J.; Roggendorf, M. Sequence diversity of hepatitis C virus: implications for immune control and therapy. In: World J. Gastroenterol. 13 (2007) S. 4808–4817.
Wallner, G.; Mandl, C. W.; Kunz, C.; Heinz, F. X. The flavivirus 3′-noncoding region: Extensive size heterogenicity independent of evolutionary relationships among strains of tick-borne encephalitis virus. In: Virology 213 (1995) S. 169–178.
White, D. J.; Morse, D. L. West-Nile-Virus: Detection, Surveillance and Control. In: Am. N.Y. Acad. Sci. 951 (2001) S. 1–374.
Wilson, J. R.; de Sessions, P. F.; Leon, M. A.; Scholle, F. West Nile virus nonstructural protein 1 inhibits TLR3 signal transduction. In: J. Virol. 82 (2008) S. 8262–8271.
Yamshchikov, V. F.; Compans, R. W. Formation of flavivirus envelope: role of the viral NS2B-NS3 protease. In: J. Virol. 96 (1995) S. 1995–2003.
Zhou, Y.; Ray, D.; Zhao.; Y, Dong.; H, Ren.; S, Li.; Z, Guo.; Y, Bernard, K. A.; Shi, P. Y.; Li, H. Structure and function of flavivirus NS5 methyltransferase. In: J. Virol. 81 (2007) S. 3891–3903.
Weiterführende Literatur
Angelini, R.; Finarelli, A. C.; Angelini, P.; Po, C.; Petropulacos, K.; Silvi, G.; Macini, P.; Fortuna, C.; Venturi, G.; Magurano, F.; Fiorentini, C.; Marchi, A.; Benedetti, E.; Bucci, P.; Boros, S.; Romi, R.; Majori, G.; Ciufolini, M. G.; Nicoletti, L.; Rezza, G.; Cassone, A. Chikungunya in north-eastern Italy: a summing up of the outbreak. In: Euro. Surveill. 12 (2007) 071122.2.
Banatvala, J. E.; Brown, D. W. Rubella. In: Lancet 363 (2004) S. 1127–1137.
Chen, J.; Strauss, J. H.; Strauss, E. G.; Frey, T. K. Characterization of the rubella virus nonstructural protease domain and its cleavage site. In: J. Virol. 70 (1996) S. 4707–4713.
Chevillon, C.; Briant, L.; Renaud, F.; Devaux, C. The Chikungunya threat: an ecological and evolutionary perspective. In: Trends Microbiol. 16 (2008) S. 80–88.
Fontana, J.; Tzeng, W. P.; Calderita, G.; Fraile-Ramos, A.; Frey, T. K.; Risco, C. Novel replication complex architecture in rubella replicon-transfected cells. In: Cell Microbiol. 9 (2007) S. 875–890.
Frey, T. K. Molecular biology of rubella virus. In: Adv. Virus Res. 44 (1994) S. 69–160.
Gonzalez, M. E.; Carrasco, L. Viroporins. In: FEBS Lett. 552 (2003) S. 28–34.
Gould, E. A.; Coutard, B.; Malet, H.; Morin, B.; Jamal, S.; Weaver, S.; Gorbalenya, A.; Moureau, G.; Baronti, C.; Delogu, I.; Forrester, N.; Khasnatinov, M.; Gritsun, T.; de Lamballerie, X.; Canard, B. Understanding the alphaviruses: Recent research on important emerging pathogens and progress towards their control. In: Antiviral Res. (2009) doi:10.1016/ j.antiviral.2009.07.007
Greene, I. P.; Paessler, S.; Austgen, L.; Anishchenko, M.; Brault, A. C.; Bowen, R. A.; Weaver, S. C. Envelope glycoprotein mutations mediate equine amplification and virulence of epizootic venezuelan equine encephalitis virus. In: J. Virol. 79 (2005) S. 9128–9133.
Kiiver, K.; Tagen, I.; Zusinaite, E.; Tamberg, N.; Fazakerley, J. K.; Merits, A. Properties of non-structural protein 1 of Semliki Forest virus and its interference with virus replication. In: J. Gen. Virol. 89 (2008) S. 1457–1466.
Law, L. M.; Everitt, J. C.; Beatch, M. D.; Holmes, C. F.; Hobman, T. C. Phosphorylation of rubella virus capsid regulates its RNA binding activity and virus replication. In: J. Virol. 77 (2003) S. 1764–1771.
Lin X.; Yang, J.; Ghazi, A. M.; Frey, T. K. Characterization of the Zinc Binding acitvity of the Rubella Virus nonstructural protease. In: J. Virol. 74 (2000) S. 5949–5956.
Melton, J. V.; Ewart, G. D.; Weir, R. C.; Board, P. G.; Lee, E.; Gage, P. W. Alphavirus 6K proteins form ion channels. In: J. Biol. Chem. 277 (2002) S. 46923–46931.
Powers, A. M.; Brault, A. C.; Shirako, Y.; Strauss, E. G.; Kang, W.; Strauss, J. H.; Weaver, C. Evolutionary relationships and systematics of the alphaviruses. In: J. Virol. 75 (2001) S. 10118–10131.
Powers, A. M.; Logue, C. H. Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus. In: J. Gen. Virol. 88 (2007) S. 2363–2377.
Shirako, Y.; Strauss, J. H. Regulation of sindbis virus RNA replication: uncleaved p123 and nsP4 function in minus strand RNA synthesis wheras cleaved products from p123 are required for efficient plus-strand synthesis. In: J. Virol. 68 (1994) S. 1874–1885.
Singh, N. K.; Atreya, C. D.; Nakhasi, H. L. Identification of calreticulin as a rubella virus RNA binding protein. In: Proc. Natl. Acad. Sci. 91 (1994) S. 12770–12774.
Spuul, P.; Salonen, A.; Merits, A.; Jokitalo, E.; Kääriäinen, L.; Ahola, T. Role of the amphipathic peptide of Semliki forest virus replicase protein nsP1 in membrane association and virus replication. In: J. Virol. 81 (2007) S. 872–883.
Weaver, S. C.; Powers, A. M.; Brault, A. C.; Barrett, A. D. Molecular epidemiological studies of veterinary arboviral encephalitides. In: The Veterinary Journal 157 (1999) S. 123–128.
Weaver, S. C.; Pfeffer, M.; Marriott, K.; Kang, W.; Kinney, R. M. Genetic evidence for the origins of Venezuelan equine encephalitis virus subtype IAB outbreaks. In: Am. J. Trop. Med. Hyg. 60 (1999) S. 441–448.
Wolinsky, J. S. Rubella Virus. In: Fields, B. N.; Knipe, D. N.; Howley, P. M. (Hrsg.) Virology. 3. Aufl. New York (Raven Press) 1995. S. 899–930.
Zhou, Y.; Tzeng, W. P.; Yang, W.; Zhou, Y.; Ye, Y.; Lee, H. W.; Frey, T. K.; Yang, J. Identification of a Ca2 +-binding domain in the rubella virus non-structural protease. In: J. Virol. 81 (2007) S. 7517–7528.
Zhou, Y.; Ushijima, H.; Frey, T. K. Genomic analysis of diverse rubella virus genotypes. In: J. Gen. Virol. 88 (2007) S. 932–941.
Zusinaite, E.; Tints, K.; Kiiver, K.; Spuul, P.; Karo-Astover, L.; Merits, A.; Sarand, I. Mutations at the palmitoylation site of non-structural protein nsP1 of Semliki Forest virus attenuate virus replication and cause accumulation of compensatory mutations. In: J. Gen. Virol. 88 (2007) S. 1977–1985.
Weiterführende Literatur
Balasriya, U. B. R.; Snijder, E. J. Arteriviruses. In: Mettenleiter, T. C.; Sobrino, F. (Hrsg.) Animal viruses. 2008 (Molecular Biology. Caister Academic Press) S. 97–148.
Calvert, J. G.; Slade, D. E.; Shields, S. L.; Jolie, R.; Mannan, R. M.; Ankenbauer, R. G.; Welch, S. K. CD163 expression confers susceptibility to porcine reproductive and respiratory syndrome viruses. In: J. Virol. 81 (2007) S. 7371–7379.
Delputte, P. L.; Van Breedam, W.; Delrue, I.; Oetke, C.; Crocker, P. R.; Nauwynck, H. J. Porcine arterivirus attachment to the macrophage-specific receptor sialoadhesin is dependent on the sialic acid-binding activity of the N-terminal immunoglobulin domain of sialoadhesin. In: J. Virol. 81 (2007) S. 9546–9550.
Lee, C.; Yoo. D. The small envelope protein of porcine reproductive and respiratory syndrome virus possesses ion channel protein-like properties. In: Virology 355 (2006) S. 30–43.
MacLachlan, N. J.; Balasuriya, U. B. Equine viral arteritis. In: Adv. Exp. Med. Biol. 581 (2006) S. 429–433.
Posthuma, C. C.; Nedialkova, D. D.; Zevenhoven-Dobbe, J. C.; Blokhuis, J. H.; Gorbalenya, A. E.; Snijder, E. J. Site-directed mutagenesis of the Nidovirus replicative endoribonuclease NendoU exerts pleiotropic effects on the arterivirus life cycle. In: J. Virol. 80 (2006) S. 1653–1661.
Snijder, E. J.; Meulenberg, J. J. M. The molecular biology of arteriviruses. In: J. Gen. Virol. 79 (1998) S. 961–979.
Van Marle, G.; Dobbe, J. C.; Gultyaev, A. P.; Luyties, W.; Spaan, W. J.; Snijder, E. J. Arterivirus discontinuous mRNA transcription is guided by base pairing between sense and antisense transcription-regulating sequences. In: Proc. Natl. Acad. Sci. USA 96 (1999) S. 12056–12061.
Ziebuhr, J.; Snijder, E. J.; Gorbalenya, A. E. Virus-encoded proteinases and proteolytic processing in the Nidovirales. In: J. Gen. Virol. 81 (2000) S. 853–879.
Weiterführende Literatur
Brian, D. A.; Baric, R. S. Coronavirus genome structure and replication. In: Curr. Top. Microbiol. Immunol. 287 (2005) S. 1–30.
Cheng, V. C.; Lau, S. K.; Woo, P. C.; Yuen, K. Y. Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. In: Clin. Microbiol. Rev. 20 (2007) S. 660–694.
Clementz, M. A.; Kanjanahaluethai, A.; O’Brien, T. E.; Baker, S. C. Mutation in murine coronavirus replication protein nsp4 alters assembly of double membrane vesicles. In: Virology 375 (2008) S. 118–129.
Cornillez-Ty, C. T.; Liao, L.; Yates, J. R. 3rd.; Kuhn, P.; Buchmeier, M. J. SARS Coronavirus nonstructural protein 2 interacts with a host protein complex involved in mitochondrial biogenesis and intracellular signaling. In: J. Virol. 83 (2009) S. 10314–10318
Deming, D. J.; Graham, R. L.; Denison, M. R.; Baric, R. S. Processing of open reading frame 1a replicase proteins nsp7 to nsp10 in murine hepatitis virus strain A59 replication. In: J. Virol. 81 (2007) S. 10280–10291.
Diemer, C.; Schneider, M.; Seebach, J.; Quaas, J.; Frösner, G.; Schätzl, H. M.; Gilch, S. Cell type-specific cleavage of nucleocapsid protein by effector caspases during SARS coronavirus infection. In: J. Mol. Biol. 376 (2008) S. 23–34.
Enjuanes, L.; Almazán, F.; Sola, I.; Zuñiga, S. Biochemical aspects of coronavirus replication and virus-host interaction. In: Annu. Rev. Microbiol. 60 (2006) S. 211–230.
Drosten, C.; Günher S.; Preiser, W.; van der Werf, S.; Brodt, H. R.; Becker, S.; Rabenau, H.; Panning, M.; Kolesnikova, L.; Fouchier, R. A. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. In: N. Engl. J. Med. 348 (2003) S. 1967–1976.
Guo, Y.; Korteweg, C.; McNutt, M. A.; Gu, J. Pathogenetic mechanisms of severe acute respiratory syndrome. In: Virus Res. 133 (2008) S. 4–12.
Hofmann, H.; Simmons, G..; Rennekamp, A. J.; Chaipan, C.; Gramberg, T.; Heck, E.; Geier, M.; Wegele, A.; Marzi, A.; Bates, P.; Pöhlmann, S. Highly conserved regions within the spike proteins of human coronaviruses 229E and NL63 determine recognition of their respective cellular receptors. In: J. Virol. 80 (2006) S. 8639–8652.
Hofmann, H.; Pyrc, K.; van der Hoek, L.; Geier, M.; Berkhout, B.; Pöhlmann, S. Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. In: Proc. Natl. Acad. Sci. USA 102 (2005) S. 7988–7993.
Hofmann, H.; Pöhlmann, S. Cellular entry of the SARS coronavirus. In: Trends in Microbiology 12 (2004) S. 466–472.
Holmes, E. C.; Rambaut, A. Viral evolution and the emergence of SARS coronavirus. In: Phil. Trans. R. Soc. Lond. B 359 (2004) S. 1059–1065.
Holmes, K. V; Lai, M. M. Coronaviridae: The viruses and their replication. In: Fields, B. N.; Knipe, D. N.; Howley, P. M. (Hrsg.) Virology. 3. Aufl. New York (Raven Press) 1995. S. 1075–1094.
Kennedy, M.; Boedeker, N.; Gibbs, P.; Kania, S. Deletions in the 7a ORF of feline coronavirus associated with an epidemic of feline infectious peritonitis. In: Vet. Microbiol. 81 (2001) S. 227–234.
Lai, M. M.; Cavanagh, D. The molecular biology of coronaviruses. In: Adv. Virus Res. 48 (1997) S. 1–100.
Lau, Y. L.; Peiris, J. S. M. Pathogenesis of the severe acute respiratory syndrome. In: Curr. Opin. Immunol. 17 (2005) S. 404–410.
Luo, Z. L.; Weiss, S. R. Mutational analysis of fusion peptide-like regions in the mouse hepatitis virus strain A59 spike protein. In: Adv. Exp. Med. Biol. 440 (1998) S. 17–23.
Myint, S.; Manley, R.; Cubitt, D. Viruses in bathing waters. In: Lancet 343 (1994) S. 1640 f.
Narayanan, K.; Huang, C.; Makino, S. SARS coronavirus accessory proteins. In: Virus Res. 133 (2008) S. 113–121.
Narayanan, K.; Huang, C.; Lokugamage, K.; Kamitani, W.; Ikegami, T.; Tseng, C. T.; Makino, S. Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells. In: J. Virol. 82 (2008) S. 4471–4479.
Olsen, C. W.; Corapi, W. V.; Jacobson, R. H.; Simkins, R. A.; Saif, L. J.; Scott, F. W. Identification of antigenic sites mediating antibody-dependent enhancement of feline infectious peritonitis virus infectivity. In: J. Gen. Virol. 74 (1993) S. 745–749.
Pasternak, A. O.; Spaan, W. J.; Snijder, E. J. Nidovirus transcription: how to make sense …? In: J. Gen. Virol. 87 (2006) S. 1403–1421.
Perlman, S.; Netland, J. Coronaviruses post-SARS: update on replication and pathogenesis. In: Nat. Rev. Microbiol. 7 (2009) S. 439–450.
Sperry, S. M.; Kazi, L.; Graham, R. L.; Baric, R. S.; Weiss, S. R.; Denison, M. R. Single-amino-acid substitutions in open reading frame (ORF) 1b-nsp14 and ORF 2a proteins of the coronavirus mouse hepatitis virus are attenuating in mice. In: J. Virol. 79 (2005) S. 3391–3400.
Stavrinides, J.; Guttman, D. S. Mosaic evolution of the severe acute respiratory syndrome coronavirus. In: J. Virol. 78 (2004) S. 76–82.
Surjit, M.; Lal, S. K. The SARS-CoV nucleocapsid protein: a protein with multifarious activities. In: Infect. Genet. Evol. 8 (2008) S. 397–405.
Thiel, V.; Weber, F. Interferon and cytokine responses to SARScoronavirus infection. In: Cytokine Growth Factor Rev. 19 (2008) S. 121–132.
Thiel, V.; Herold, J.; Schelle, B.; Siddell, S. G. Viral replicase gene products suffice for coronavirus discontinous transcription. In: J. Virol. 75 (2001) S. 6676–6681.
Tresnan, D. B.; Holmes, K. V. Feline aminopeptidase N is a receptor for all group I coronaviruses. In: Adv. Exp. Med. Biol. 440 (1998) S. 69–75.
van der Hoek, L. Human coronaviruses: what do they cause? In: Antivir. Ther. 12 (2007) S. 651–658.
Vennema, H.; Poland, A.; Foley, J.; Pedersen, N. C. Feline infectious peritonitis viruses arise by mutation from endemic feline enteric coronaviruses. In: J. Virol. 243 (1998) S. 150–157.
Wang, L. F.; Eaton, B. T. Bats, civets and the emergence of SARS. In: Curr. Top. Microbiol. Immunol. 315 (2007) S. 325–344.
Wong, S.; Lau, S.; Woo, P.; Yuen, K. Y. Bats as a continuing source of emerging infections in humans. In: Rev. Med. Virol. 17 (2007) S. 67–91.
You, J. H.; Reed, M. L.; Hiscox, J. A. Trafficking motifs in the SARS-coronavirus nucleocapsid protein. In: Biochem. Biophys. Res. Commun. 358 (2007) S. 1015–1020.
Zhang, X.; Wu, K.; Wang, D.; Yue, X.; Song, D.; Zhu, Y.; Wu, J. Nucleocapsid protein of SARS-CoV activates interleukin-6 expression through cellular transcription factor NF-kappaB. In: Virology 365 (2007) S. 324–335.
Ziebuhr, J. Molecular biology of severe acute respirator syndrome. In: Curr. Opin. Microbiol. 7 (2004) S. 412–419.
Ziebuhr, J.; Snijder, E. J.; Gorbalenya, A. E. Virus-encoded proteinases and proteolytic processing in the Nidovirales. In: J. Gen. Virol. 81 (2000) S. 853–879.
Züst, R.; Cervantes-Barragán, L.; Kuri, T.; Blakqori, G.; Weber, F.; Ludewig, B.; Thiel, V. Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines. In: PLoS Pathog. 3 (2007) e109.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2010 Spektrum Akademischer Verlag Heidelberg
About this chapter
Cite this chapter
Modrow, S., Falke, D., Truyen, U., Schätzl, H. (2010). Viren mit einzelsträngigem RNA-Genom in Plusstrangorientierung. In: Molekulare Virologie. Spektrum Akademischer Verlag. https://doi.org/10.1007/978-3-8274-2241-5_14
Download citation
DOI: https://doi.org/10.1007/978-3-8274-2241-5_14
Publisher Name: Spektrum Akademischer Verlag
Print ISBN: 978-3-8274-1833-3
Online ISBN: 978-3-8274-2241-5
eBook Packages: Life Science and Basic Disciplines (German Language)